ZG-126
ZG-126 is an agonist for vitamin D receptor (VDR) and an inhibitor for histone deacetylase (HDAC) (IC50=0.63-67.6 μM) . ZG-126 exhibits cytotoxicity in cancer cells MDA-MB-231 and 4T1. ZG-126 exhibits antitumor and anti-metastatic efficacy against melanoma and triple-negative breast cancer (TNBC) in mouse models. ZG-126 also exhibits anti-inflammatory activity, through the reduction of macrophage infiltration and immunosuppressive M2-polarization[1].
Product Specifications
CAS Number
[3049802-32-3]
UNSPSC
12352005
Target
HDAC; VD/VDR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-anti-virus
Field of Research
Cancer; Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/zg-126.html
Smiles
CCC(CC)(C1=CC=C(C=C1)C(NCCCCC(NO)=O)=O)C2=NC(C)=C(C=C2)OCC(C(C)(C)C)O
Molecular Formula
C29H43N3O5
Molecular Weight
513.67
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
HDAC1; HDAC10; HDAC11; HDAC2; HDAC3; HDAC4; HDAC5; HDAC6; HDAC7; HDAC8
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Lentiviral human CD86 shRNA (UAS) - Lentiviral human CD86 shRNA (UAS) (25)
